DaVita
DVA
#2385
Rank
HK$61.07 B
Marketcap
HK$854.24
Share price
1.96%
Change (1 day)
-37.88%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): HK$77.47

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$77.66. In 2024 the company made an earnings per share (EPS) of HK$86.17 an increase over its 2023 EPS that were of HK$59.45.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$77.47-10.1%
2024HK$86.1744.94%
2023HK$59.4527.26%
2022HK$46.72-35.56%
2021HK$72.5044.1%
2020HK$50.3119.7%
2019HK$42.03540.48%
2018HK$6.56-76.07%
2017HK$27.42-19.31%
2016HK$33.99242.52%
2015HK$9.92-62.87%
2014HK$26.7213.43%
2013HK$23.568.45%
2012HK$21.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
HK$166.80 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$80.08 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$114.85 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$14.83-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA